Publication | Closed Access

High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group

Neuro-oncologyLymphoid NeoplasiaCell TherapyTransplantationOncologyStem Cell TransplantationPrimary Cns LymphomaGoelams GroupHigh-dose ChemotherapyRadiation OncologyMedicineCell Transplantation